Health equity is an ambitious goal, but the drive to deliver life-changing innovation to all eligible patients is ...

The industry is now entering the next era by embedding AI directly into the software field teams’ use every day. The step ...

Nektar Therapeutics has announced top-line results from its trial of rezpegaldesleukin to treat severe to very severe ...

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der ...

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Follow-up results from the phase 3 EMBER-3 study showed that, as a monotherapy, Inluriyo demonstrated a 38% reduction in the ...

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to ...

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional ...

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to ...

Building a trusted data foundation The starting line for any successful AI journey is data readiness and quality. Before ...

Creative agency Havas Life London has launched an impactful new campaign, ‘The World’s Rarest Disease’, highlighting the ...

Galderma’s Nemluvio (nemolizumab) has shown rapid relief of itch, as well as improvement in sleep, in patients with atopic ...